Getinge AB – Investor Interest and Bond Activity in September 2025
Share price context
On 29 May 2025 the share price of Getinge AB closed at 186.5 SEK. The company’s market capitalization was 57,143,136,256 SEK, and its price‑earnings ratio stood at 38.35.
Institutional ownership
On 8 September 2025 the pension fund AMF Tjänstepension announced that its stake in Getinge had increased to 8.08 % of the capital and 5.05 % of the voting rights. The next day the fund reported an ownership of 8.10 % and 5.10 % voting power, reflecting a continued accumulation of shares. The increase in voting proportion exceeded the 5 % threshold that triggers a public disclosure (flaggningsmeddelande) by Swedish regulation, thereby attracting attention from market participants.
Bond issuances
Two Swedish‑listed investment funds disclosed participation in Getinge’s debt instruments during August 2025:
- Öhman Företagsobligationsfond – The fund reported a 0.7 % increase in its holdings, in line with its benchmark index, and a year‑to‑date return of 3.5 %.
- Lannebo Sustainable Corporate Bond A – The fund increased its exposure by 0.5 % in August, outperforming its benchmark by 0.1 %. Its year‑to‑date return was 3.3 %.
The bond activity indicates that institutional investors are actively allocating capital to Getinge’s corporate debt, suggesting confidence in the company’s credit profile.
Sector relevance
Getinge operates in the health‑care equipment and supplies sector, offering solutions for operating rooms, intensive‑care units, sterilization departments, and life‑science applications. The company’s segments—Acute Care Therapies, Surgical Workflows, and Life Science—align with growing demand for advanced medical technologies, particularly in light of recent market projections for diagnostic platforms such as lateral flow assays.
Conclusion
The combination of increased institutional ownership, active bond participation, and a solid market position within the health‑care equipment sector positions Getinge AB as a focal point for investors seeking exposure to the Swedish medical‑device industry.